- Financial Information
- Official Notices to the CNMV
- Share Information
- Debt obligations
- Oncology pipeline
- Events Calendar
- General Shareholders Meetings
- Corporate Governance
- Merger PharmaMar-Zeltia
- Política de comunicación con accionistas
Board of Directors
José María Fernández Sousa-Faro obtained a primary degree in Chemistry (1967) and a PhD in Biochemistry (1971) from Madrid Complutense University. Between 1971 and 1979, he was tenured professor and subsequently held the Chair of Biochemistry at the University of Santiago de Compostela. He also obtained an MBA from IESE (University of Navarra) in Madrid.
Between 1967 and 1979, he also worked at the following institutions: Institut für Physikalische Chemie at the University of Basel (Switzerland), Department of Molecular Biology at Washington University in Saint Louis, Missouri (USA), and L’Institut de Biologie Physico-Chimique at the Fondation Edmond de Rothschild in Paris, France, ICI Pharmaceuticals Division (Alderley Edge research labs) and Shell (Sittingbourne research labs). He has over 100 academic publications and patents in the fields of biochemistry, molecular biology, and anti-infective and anti-tumour drugs.
Between 1979 and 1985, Mr. Fernández Sousa-Faro was Research Director at Antibióticos, S.A. He has been a member of the Board of the following companies: Antibióticos, S.A.; ICI-Farma, S.A.; Transportes Ferroviarios Especiales, S.A. (Transfesa); Pescanova, S.A.; Cooper Zeltia, S.A.; Biolys, S.A.; ICI-Zeltia, S.A.; Penibérica; S.A.; Banco Guipuzcoano, S.A.; and Zeltia.
He is currently Chairman of the Board of Directors of Genómica, S.A. and Sylentis, S.A., and a director of Zelnova, S.A. (all three companies are owned by PharmaMar). He is also Chairman of Fundación Bankinter para la Innovación.
He received an Honorary Doctorate from Antonio de Nebrija University and was awarded Spain’s National Biotechnology Prize, both in 2009.
Pedro Fernández Puentes graduated in Chemistry from the University of Santiago de Compostela.
Between 1965 and 1971, Mr. Fernández Puentes worked as Head of the new product development lab at Cooper Zeltia, S.A., and became Chairman of that company until it was demerged into Zelnova, S.A. y Cooper Zeltia Veterinaria, S.A. He was Chairman of Xylazel, S.A. from 1995 to 1997. As for directorships, he was a member of the Board of Directors of ICI Farma, S.A., ICI-Zeltia, S.A., Corporación Noroeste, S.A. and their main subsidiaries for approximately 20 years; he was director of Zeltia from 1971 onwards.
He is currently Chairman of Zelnova, S.A. and a director and Vice-Chairman of PharmaMar.
Rosp Corunna Participaciones Empresariales, S.L. (represented by José Leyte Verdejo)
José Leyte Verdejo graduated in Law and Business from Comillas Pontifical University (ICADE).
After graduation, he worked for four years at Arthur Anderson Asesores Legales y Tributarios. He then joined Barclays Banks and was head of Deutsche Bank’s Private Banking department for Galicia and Asturias. Before taking his current position, he headed Caixa Galicia’s Private Banking division.
Since 2000, he has been the chief executive of Rosp Corunna Participaciones Empresariales, S.L., the family office of the late Rosalía Mera and now of her daughter, Sandra Ortega. Mr. Leyte Verdejo also teaches post-graduate courses at a number of academic institutions.
He was formerly a director of Zeltia and is currently a member of the Board of Directors of PharmaMar representing Rosp Corunna Participaciones Empresariales, S.L.
Ana Palacio Vallelersundi holds degrees in Law and in Sociology and Political Science (Special end of degree award). She is Honorary Doctorate from Georgetown University and in 2016 she has been awarded the Sandra Day O’Connor Justice Prize.
She is an attorney specialised in international and European Union law, arbitration and mediation, and a founder of the Palacio y Asociados law firm. Between 1994 and 2002, she was a member of the European Parliament, where she chaired the Legal Affairs and Internal Market Committee, the Justice and Home Affairs Committee and the Conference of Committee Chairs. Former positions include: Spain’s Minister of Foreign Affairs from 2002 to 2004, Member of the Spanish Parliament in its VIII Legislature, timeframe in which she chaired the Joint Congress of Deputies and Senate Commission for the European Union (2004-2006). She was subsequently appointed Senior Vice-President and General Counsel of the World Bank, and was General Secretary of the International Centre for the Settlement of Investment Disputes (ICSID).
In March 2012, she was appointed an Elective Member of Spain’s Council of State, a position that she holds at present. She is also lead Independent Coordinating Director on the Board of Enagás and a member of Invercorp’s International Advisory Board. She sits on the Boards of a number of research centres and public institutions, including: MD Anderson Cancer Center; Atlantic Council (USA); Institute for Strategic Dialogue; Le Conseil d’Orientation et de Réflexion de l’Assurance (CORA); and the World Economic Forum’s Global Agenda Council. In Spain, she is a member of the Scientific Board of Instituto Elcano and a trustee of Fundación para el Análisis y los Estudios Sociales (FAES).
She has been visiting professor of the Edmund E. Walsh School of Foreign Service at Georgetown University since 2014.
He graduated in Pharmacy from the University of Navarra and also obtained a degree in Law; he obtained an MBA from IESE (Barcelona) in 1971, and an MSc from Harvard Business School in 1978.
He was manager of Antibióticos, S.A. in the USA from 1979 to 1984, and General Manager in Spain from 1984 to 1987.Since 1987, he has been Chairman of Pérez Orive & Asociados, a company specialised in mergers and acquisitions. He has been a director of over thirty companies and given over 100 keynote lectures to major institutions.
He was a member of the Board of Directors of Zeltia from June 1990 onwards. JEFPO, S.L. is also Vice-Chair of Xylazel, S.A. and a director of Zelnova, S.A., both of which are owned by PharmaMar. Mr. Pérez-Orive is currently a director of PharmaMar and Genómica, S.A., both companies belong to Pharma Mar Group.
PhD in Law. Professor of Mercantile Law. Practising lawyer.
Ms. Andrade graduated in Biology in 1975, holds a degree in Medicine (1983) and received a diploma in Family and Community Medicine from Madrid Complutense University in 1983. She obtained a Master’s degree in Pathologie du Sein from the University of Strasbourg, France (1991), a postgraduate diploma in Mammary Pathology from the University of Barcelona (1992), and a Master’s degree in that same field one year later; in 1996, she qualified as a specialist in Medicine of the Breast and Mammary Pathology from the Complutense University of Madrid.
Additionally, Montserrat Andrade is certified to supervise X-ray facilities for medical diagnostics by the Centro de Investigaciones Energéticas y Medioambientales y Tecnológicas attached to the Spanish Ministry of Industry and Energy (1991). She completed her internship at Hospital Universitario San Carlos in Madrid (1985–1988), obtained a PhD. from San Carlos University in Madrid, and her degree dissertation at the Complutense University of Madrid was granted honours.
She was Head of Institutional Relations at Zeltia, S.A. from 2007 to 2012, and is currently a member of the Board of PharmaMar.
Eduardo Serra graduated with a degree in Law from Madrid Complutense University and passed the exams to enter the Spanish civil service as a lawyer with the highest marks of that year.
He has held the following positions in the public sector: Chief of Staff to the Minister of Industry and Energy (1977-1979); General Secretary and Board Secretary of Spain’s National Industry Institute (INI) (1979-1982); director of Banco del Crédito Industrial (1979-1982); director of Butano (1979-1982); Vice-Chairman of Astilleros Españoles (1979-1982) and Chairman of Auxina (1979-1982); Under-Secretary of Defence (1982-1984); Secretary of State for Defence (1984-1987); director of Instituto Nacional de Industria (1984-1987) and of Instituto Nacional de Hidrocarburos (INH) (1984-1987). He was Spain’s Minister of Defence from 1996 to 2000.
In the private sector, from 1987 to 1996 he was Chairman of Telettra España, Vice-Chairman and subsequently Chairman of Cubiertas Mzov, Chairman of Peugeot-Talbot España, and Chairman of Airtel. From 2000 to 2006, he was Chairman of UBS España.
He was also formerly Chairman of Instituto de Cuestiones Internacionales y Política Exterior (INCIPE) (1989-1996), President of the Board of Trustees of Museo del Prado (2000-2004) and founding Chairman of Real Instituto Elcano (2001-2005).
He currently heads consulting firm Eduardo Serra y Asociados, S.L., is Vice-President of Fundación EVERIS, and acts as director or trustee in numerous Spanish and international institutions.
Carlos Solchaga Catalán graduated in Economics and Business from Madrid Complutense University (1996) and completed post-graduate studies at the Alfred P. Sloan School of Business at Massachusetts Institute of Technology (MIT) in 1971.
He began his career at the Bank of Spain, then transferred to the Instituto Nacional de Industria (INI) and subsequently to Banco de Vizcaya, where he was Director of Research and Advisor to the Chairman. He was Spain’s Minister of Industry and Energy between 1982 and 1985 and later Minister of Economy and Finance between 1985 and 1993. Between 1991 and 1993, he was Chairman of the Internal Committee of the International Monetary Fund (IMF). He was a member of the Spanish parliament from 1980 to 1994, and headed the Socialist parliamentary group in 1993-1994.
Current positions at other institutions include notably: Chair of Solchaga Recio & Asociados; Honorary President of Fundación Euroamérica; Vice-President of the Board of Trustees of Museo Centro de Arte Reina Sofía; President of Fundación Arquitectura y Sociedad; President of the Advisory Board of Bufete Roca & Junyent; Member of the Scientific Committee of Real Instituto Elcano; and director of Duro Felguera, S.A. and of Cie Automotive, S.A.